Armen Aprikian
Direttore/Membro del Consiglio presso Nanostics, Inc.
Profilo
Armen G.
Aprikian is currently the Director at Nanostics, Inc. and the Head of Urology Division & Surgery Department at McGill University.
He previously worked as a Director at Telesta Therapeutics, Inc. and as the Interim Chief of Oncology Department at McGill University Health Center.
Dr. Aprikian obtained a doctorate degree from the University of Sherbrooke.
Posizioni attive di Armen Aprikian
| Società | Posizione | Inizio |
|---|---|---|
| McGill University | Corporate Officer/Principal | 20/08/2009 |
Nanostics, Inc.
 Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Armen Aprikian
| Società | Posizione | Fine |
|---|---|---|
McGill University Health Center
 McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - |
| TELESTA THERAPEUTICS INC | Direttore/Membro del Consiglio | - |
Formazione di Armen Aprikian
| University of Sherbrooke | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
McGill University Health Center
McGill University Health Center Hospital/Nursing ManagementHealth Services McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Services |
Nanostics, Inc.
Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Health Technology |
- Borsa valori
- Insiders
- Armen Aprikian
